Eton Pharmaceuticals, Inc. (ETON) research: valuation against peers, fundamentals over time, risk and news coverage
ChartVs peersValuationValue mapQuartersScaleMarginsTrajectoryCash qualityPer shareReinvestmentBalance sheetStreetRiskSeasonalityOur coverage
ETON
Eton Pharmaceuticals, Inc.USD
63.47
+5.94% today
Market cap
—
P/E trailing
—
P/E forward
—
EV/EBITDA
—
Op margin
—
Rev growth
—
Div yield
—
Beta
—
Price navigator — ETON
No data in this window.
INDY NEWS coverage of ETON1
Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.
- SPECIAL REPORTNEUTRALExecutives Across Tech, Retail And Mining Cash Out In Broad Insider Selling Wave
DST Global Advisors, a 10% owner of Chime Financial, sold $156.9 million in stock, the largest of more than a dozen insider sales disclosed across sectors including tech, retail, mining and biotech.
Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.